immunoglobulin heavy chain gene enhancer inhibitors (Leukogene Therapeutics)

N/A

Report date: 2025/03/20 14:55:45
NME

Base Information

Drug Nameimmunoglobulin heavy chain gene enhancer inhibitors (Leukogene Therapeutics)
Drug Alias NameIgH gene enhancer inhibitors (Leukogene Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunoglobulin G inhibitors
TargetsImmunoglobulin G
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeukogene Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeukogene Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A